Tag Archives: Moungi Bawendi

Brain-inspired (neuromrophic) computing with twisted magnets and a patent for manufacturing permanent magnets without rare earths

Leave a reply

I have two news bits both of them concerned with magnets.

Patent for magnets that can be made without rare earths

I’m starting with the patent news first since this is (as the company notes in its news release) a “Landmark Patent Issued for Technology Critically Needed to Combat Chinese Monopoly.”

For those who don’t know, China supplies most of the rare earths used in computers, smart phones, and other devices. On general principles, having a single supplier dominate production of and access to a necessary material for devices that most of us rely on can raise tensions. Plus, you can’t mine for resources forever.

This December 19, 2023 Nanocrystal Technology LP news release heralds an exciting development (for the impatient, further down the page I have highlighted the salient sections),

Nanotechnology Discovery by 2023 Nobel Prize Winner Became Launch Pad to Create Permanent Magnets without Rare Earths from China

NEW YORK, NY, UNITED STATES, December 19, 2023 /EINPresswire.com/ — Integrated Nano-Magnetics Corp, a wholly owned subsidiary of Nanocrystal Technology LP, was awarded a patent for technology built upon a fundamental nanoscience discovery made by Aleksey Yekimov, its former Chief Scientific Officer.

This patent will enable the creation of strong permanent magnets which are critically needed for both industrial and military applications but cannot be manufactured without certain “rare earth” elements available mostly from China.

At a glittering awards ceremony held in Stockholm on December10, 2023, three scientists, Aleksey Yekimov, Louis Brus (Professor at Columbia University) and Moungi Bawendi (Professor at MIT) were honored with the Nobel Prize in Chemistry for their discovery of the “quantum dot” which is now fueling practical applications in tuning the colors of LEDs, increasing the resolution of TV screens, and improving MRI imaging.

As stated by the Royal Swedish Academy of Sciences, “Quantum dots are … bringing the greatest benefits to humankind. Researchers believe that in the future they could contribute to flexible electronics, tiny sensors, thinner solar cells, and encrypted quantum communications – so we have just started exploring the potential of these tiny particles.”

Aleksey Yekimov worked for over 19 years until his retirement as Chief Scientific Officer of Nanocrystals Technology LP, an R & D company in New York founded by two Indian-American entrepreneurs, Rameshwar Bhargava and Rajan Pillai.

Yekimov, who was born in Russia, had already received the highest scientific honors for his work before he immigrated to USA in 1999. Yekimov was greatly intrigued by Nanocrystal Technology’s research project and chose to join the company as its Chief Scientific Officer.

During its early years, the company worked on efficient light generation by doping host nanoparticles about the same size as a quantum dot with an additional impurity atom. Bhargava came up with the novel idea of incorporating a single impurity atom, a dopant, into a quantum dot sized host, and thus achieve an extraordinary change in the host material’s properties such as inducing strong permanent magnetism in weak, readily available paramagnetic materials. To get a sense of the scale at which nanotechnology works, and as vividly illustrated by the Nobel Foundation, the difference in size between a quantum dot and a soccer ball is about the same as the difference between a soccer ball and planet Earth.

Currently, strong permanent magnets are manufactured from “rare earths” available mostly in China which has established a near monopoly on the supply of rare-earth based strong permanent magnets. Permanent magnets are a fundamental building block for electro-mechanical devices such as motors found in all automobiles including electric vehicles, trucks and tractors, military tanks, wind turbines, aircraft engines, missiles, etc. They are also required for the efficient functioning of audio equipment such as speakers and cell phones as well as certain magnetic storage media.

The existing market for permanent magnets is $28 billion and is projected to reach $50 billion by 2030 in view of the huge increase in usage of electric vehicles. China’s overwhelming dominance in this field has become a matter of great concern to governments of all Western and other industrialized nations. As the Wall St. Journal put it, China’s now has a “stranglehold” on the economies and security of other countries.

The possibility of making permanent magnets without the use of any rare earths mined in China has intrigued leading physicists and chemists for nearly 30 years. On December 19, 2023, a U.S. patent with the title ‘’Strong Non Rare Earth Permanent Magnets from Double Doped Magnetic Nanoparticles” was granted to Integrated Nano-Magnetics Corp. [emphasis mine] Referring to this major accomplishment Bhargava said, “The pioneering work done by Yekimov, Brus and Bawendi has provided the foundation for us to make other discoveries in nanotechnology which will be of great benefit to the world.”

I was not able to find any company websites. The best I could find is a Nanocrystals Technology LinkedIn webpage and some limited corporate data for Integrated Nano-Magnetics on opencorporates.com.

Twisted magnets and brain-inspired computing

This research offers a pathway to neuromorphic (brainlike) computing with chiral (or twisted) magnets, which, as best as I understand it, do not require rare earths. From a November13, 2023 news item on ScienceDaily,

A form of brain-inspired computing that exploits the intrinsic physical properties of a material to dramatically reduce energy use is now a step closer to reality, thanks to a new study led by UCL [University College London] and Imperial College London [ICL] researchers.

In the new study, published in the journal Nature Materials, an international team of researchers used chiral (twisted) magnets as their computational medium and found that, by applying an external magnetic field and changing temperature, the physical properties of these materials could be adapted to suit different machine-learning tasks.

…

A November 9, 2023 UCL press release (also on EurekAlert but published November 13, 2023), which originated the news item, fill s in a few more details about the research,

Dr Oscar Lee (London Centre for Nanotechnology at UCL and UCL Department of Electronic & Electrical Engineering), the lead author of the paper, said: “This work brings us a step closer to realising the full potential of physical reservoirs to create computers that not only require significantly less energy, but also adapt their computational properties to perform optimally across various tasks, just like our brains.

“The next step is to identify materials and device architectures that are commercially viable and scalable.”

Traditional computing consumes large amounts of electricity. This is partly because it has separate units for data storage and processing, meaning information has to be shuffled constantly between the two, wasting energy and producing heat. This is particularly a problem for machine learning, which requires vast datasets for processing. Training one large AI model can generate hundreds of tonnes of carbon dioxide.

Physical reservoir computing is one of several neuromorphic (or brain inspired) approaches that aims to remove the need for distinct memory and processing units, facilitating more efficient ways to process data. In addition to being a more sustainable alternative to conventional computing, physical reservoir computing could be integrated into existing circuitry to provide additional capabilities that are also energy efficient.

In the study, involving researchers in Japan and Germany, the team used a vector network analyser to determine the energy absorption of chiral magnets at different magnetic field strengths and temperatures ranging from -269 °C to room temperature.

They found that different magnetic phases of chiral magnets excelled at different types of computing task. The skyrmion phase, where magnetised particles are swirling in a vortex-like pattern, had a potent memory capacity apt for forecasting tasks. The conical phase, meanwhile, had little memory, but its non-linearity was ideal for transformation tasks and classification – for instance, identifying if an animal is a cat or dog.

Co-author Dr Jack Gartside, of Imperial College London, said: “Our collaborators at UCL in the group of Professor Hidekazu Kurebayashi recently identified a promising set of materials for powering unconventional computing. These materials are special as they can support an especially rich and varied range of magnetic textures. Working with the lead author Dr Oscar Lee, the Imperial College London group [led by Dr Gartside, Kilian Stenning and Professor Will Branford] designed a neuromorphic computing architecture to leverage the complex material properties to match the demands of a diverse set of challenging tasks. This gave great results, and showed how reconfiguring physical phases can directly tailor neuromorphic computing performance.”

The work also involved researchers at the University of Tokyo and Technische Universität München and was supported by the Leverhulme Trust, Engineering and Physical Sciences Research Council (EPSRC), Imperial College London President’s Excellence Fund for Frontier Research, Royal Academy of Engineering, the Japan Science and Technology Agency, Katsu Research Encouragement Award, Asahi Glass Foundation, and the DFG (German Research Foundation).

Here’s a link to and a citation for the paper,

Task-adaptive physical reservoir computing by Oscar Lee, Tianyi Wei, Kilian D. Stenning, Jack C. Gartside, Dan Prestwood, Shinichiro Seki, Aisha Aqeel, Kosuke Karube, Naoya Kanazawa, Yasujiro Taguchi, Christian Back, Yoshinori Tokura, Will R. Branford & Hidekazu Kurebayashi. Nature Materials volume 23, pages 79–87 (2024) DOI: https://doi.org/10.1038/s41563-023-01698-8 Published online: 13 November 2023 Issue Date: January 2024

This paper is open access.

New iron oxide nanoparticle as an MRI (magnetic resonance imaging) contrast agent

Leave a reply

This high-resolution transmission electron micrograph of particles made by the research team shows the particles’ highly uniform size and shape. These are iron oxide particles just 3 nanometers across, coated with a zwitterion layer. Their small size means they can easily be cleared through the kidneys after injection. Courtesy of the researchers

A Feb. 14, 2017 news item on ScienceDaily announces a new MRI (magnetic resonance imaging) contrast agent,

A new, specially coated iron oxide nanoparticle developed by a team at MIT [Massachusetts Institute of Technology] and elsewhere could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI) procedures. In rare cases, the currently used gadolinium agents have been found to produce adverse effects in patients with impaired kidney function.

A Feb. 14, 2017 MIT news release (also on EurekAlert), which originated the news item, provides more technical detail,

 

The advent of MRI technology, which is used to observe details of specific organs or blood vessels, has been an enormous boon to medical diagnostics over the last few decades. About a third of the 60 million MRI procedures done annually worldwide use contrast-enhancing agents, mostly containing the element gadolinium. While these contrast agents have mostly proven safe over many years of use, some rare but significant side effects have shown up in a very small subset of patients. There may soon be a safer substitute thanks to this new research.

In place of gadolinium-based contrast agents, the researchers have found that they can produce similar MRI contrast with tiny nanoparticles of iron oxide that have been treated with a zwitterion coating. (Zwitterions are molecules that have areas of both positive and negative electrical charges, which cancel out to make them neutral overall.) The findings are being published this week in the Proceedings of the National Academy of Sciences, in a paper by Moungi Bawendi, the Lester Wolfe Professor of Chemistry at MIT; He Wei, an MIT postdoc; Oliver Bruns, an MIT research scientist; Michael Kaul at the University Medical Center Hamburg-Eppendorf in Germany; and 15 others.

Contrast agents, injected into the patient during an MRI procedure and designed to be quickly cleared from the body by the kidneys afterwards, are needed to make fine details of organ structures, blood vessels, and other specific tissues clearly visible in the images. Some agents produce dark areas in the resulting image, while others produce light areas. The primary agents for producing light areas contain gadolinium.

Iron oxide particles have been largely used as negative (dark) contrast agents, but radiologists vastly prefer positive (light) contrast agents such as gadolinium-based agents, as negative contrast can sometimes be difficult to distinguish from certain imaging artifacts and internal bleeding. But while the gadolinium-based agents have become the standard, evidence shows that in some very rare cases they can lead to an untreatable condition called nephrogenic systemic fibrosis, which can be fatal. In addition, evidence now shows that the gadolinium can build up in the brain, and although no effects of this buildup have yet been demonstrated, the FDA is investigating it for potential harm.

“Over the last decade, more and more side effects have come to light” from the gadolinium agents, Bruns says, so that led the research team to search for alternatives. “None of these issues exist for iron oxide,” at least none that have yet been detected, he says.

The key new finding by this team was to combine two existing techniques: making very tiny particles of iron oxide, and attaching certain molecules (called surface ligands) to the outsides of these particles to optimize their characteristics. The iron oxide inorganic core is small enough to produce a pronounced positive contrast in MRI, and the zwitterionic surface ligand, which was recently developed by Wei and coworkers in the Bawendi research group, makes the iron oxide particles water-soluble, compact, and biocompatible.

The combination of a very tiny iron oxide core and an ultrathin ligand shell leads to a total hydrodynamic diameter of 4.7 nanometers, below the 5.5-nanometer renal clearance threshold. This means that the coated iron oxide should quickly clear through the kidneys and not accumulate. This renal clearance property is an important feature where the particles perform comparably to gadolinium-based contrast agents.

Now that initial tests have demonstrated the particles’ effectiveness as contrast agents, Wei and Bruns say the next step will be to do further toxicology testing to show the particles’ safety, and to continue to improve the characteristics of the material. “It’s not perfect. We have more work to do,” Bruns says. But because iron oxide has been used for so long and in so many ways, even as an iron supplement, any negative effects could likely be treated by well-established protocols, the researchers say. If all goes well, the team is considering setting up a startup company to bring the material to production.

For some patients who are currently excluded from getting MRIs because of potential side effects of gadolinium, the new agents “could allow those patients to be eligible again” for the procedure, Bruns says. And, if it does turn out that the accumulation of gadolinium in the brain has negative effects, an overall phase-out of gadolinium for such uses could be needed. “If that turned out to be the case, this could potentially be a complete replacement,” he says.

Ralph Weissleder, a physician at Massachusetts General Hospital who was not involved in this work, says, “The work is of high interest, given the limitations of gadolinium-based contrast agents, which typically have short vascular half-lives and may be contraindicated in renally compromised patients.”

The research team included researchers in MIT’s chemistry, biological engineering, nuclear science and engineering, brain and cognitive sciences, and materials science and engineering departments and its program in Health Sciences and Technology; and at the University Medical Center Hamburg-Eppendorf; Brown University; and the Massachusetts General Hospital. It was supported by the MIT-Harvard NIH Center for Cancer Nanotechnology, the Army Research Office through MIT’s Institute for Soldier Nanotechnologies, the NIH-funded Laser Biomedical Research Center, the MIT Deshpande Center, and the European Union Seventh Framework Program.

Here’s a link to and a citation for the paper,

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents by He Wei, Oliver T. Bruns, Michael G. Kaul, Eric C. Hansen, Mariya Barch, Agata Wiśniowsk, Ou Chen, Yue Chen, Nan Li, Satoshi Okada, Jose M. Cordero, Markus Heine, Christian T. Farrar, Daniel M. Montana, Gerhard Adam, Harald Ittrich, Alan Jasanoff, Peter Nielsen, and Moungi G. Bawendi. PNAS February 13, 2017 doi: 10.1073/pnas.1620145114 Published online before print February 13, 2017

This paper is behind a paywall.